SCHEMBL9079347

SCHEMBL9079347

CC(C)(C)c1ccc(OC(=O)O)o1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MITF O75030 1/20 0.40
MEN1 O00255 3/20 0.39
KMT2A Q03164 3/20 0.39
L3MBTL1 Q9Y468 2/20 0.34
TDP1 Q9NUW8 3/20 0.33
MAPT P10636 2/20 0.33
RAB9A P51151 5/20 0.32
NPC1 O15118 4/20 0.32
SMN1; SMN2 Q16637 4/20 0.32
TP53 P04637 1/20 0.32
TSHR P16473 2/20 0.31
LMNA P02545 1/20 0.31
GAA P10253 1/20 0.31
MAPK1 P28482 1/20 0.31
ALDH1A1 P00352 1/20 0.31
NPSR1 Q6W5P4 1/20 0.31
ELANE P08246 1/20 0.31
HTT P42858 1/20 0.30
ATM Q13315 1/20 0.30
RAF1 P04049 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL377017 0.80 KMT2A (0.32) MEN1KMT2ATDP1TP53TSHR
SCHEMBL11892171 0.74 LMNA (0.31) MITFTSHRLMNAGAA
SCHEMBL1823686 0.72
SCHEMBL30523484 0.72 MITF (0.30) MITF
SCHEMBL3823363 0.71 KMT2A (0.40) MEN1KMT2AL3MBTL1TDP1MAPT
SCHEMBL3225051 0.71 MITF (0.53) MITFMEN1KMT2ATDP1RAB9A
SCHEMBL6968831 0.71 KMT2A (0.41) MEN1KMT2AL3MBTL1TDP1MAPT
SCHEMBL47577 0.69 MITF (0.36) MITFMEN1KMT2AL3MBTL1TDP1
SCHEMBL11904538 0.69 TDP1 (0.45) MEN1KMT2AL3MBTL1TDP1MAPT
Hydrochloric Acid SCHEMBL11703876 0.69 MITF (0.51) MITFMEN1KMT2ATDP1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0296110-B1 Staurosporine derivatives substituted for the nitrogen atom of the methylamino group CIBA GEIGY AG (CH) 1996-02-21 EP disclosed
US-5449664-A Nucleosides SYNTEX (U.S.A.) INC. (US) 1995-09-12 US disclosed
EP-0300966-B1 PROCESS FOR THE SELECTIVE N-ACYLATION OF AMINO-HYDRAXAMIC AND DERIVATES AND STARTING COMPOUNDS THEREFOR CIBA-GEIGY AG (CH) 1992-10-14 EP disclosed
EP-0346281-B1 CARBAMOYLATED HYDROXAMIC-ACID DERIVATIVES, AND PROCESS FOR THEIR PREPARATION CIBA-GEIGY AG (CH) 1992-06-17 EP disclosed
EP-0457326-A1 Antiviral agents SYNTEX (U.S.A.) INC. (US) 1991-11-21 EP disclosed
EP-0271443-B1 N,N'-DISUBSTITUTED UREAS AND PROCESS FOR THEIR PRODUCTION CIBA-GEIGY AG (CH) 1990-10-17 EP disclosed
EP-0346281-A1 Carbamoylated hydroxamic-acid derivatives, and process for their preparation CIBA-GEIGY AG (CH) 1989-12-13 EP disclosed
EP-0300966-A2 Process for the selective N-acylation of amino-hydraxamic and derivates and starting compounds therefor CIBA-GEIGY AG (CH) 1989-01-25 EP disclosed
EP-0271443-A1 N,N'-disubstituted ureas and process for their production CIBA-GEIGY AG (CH) 1988-06-15 EP disclosed
EP-0054514-A1 Derivatives of aminopapulacandin having antibiotic activity CIBA-GEIGY AG (CH) 1982-06-23 EP disclosed
EP-0049683-A2 Imidazo-rifamycines, process for their preparation, pharmaceutical preparations containing them and their use CIBA-GEIGY AG (CH) 1982-04-14 EP disclosed
EP-0023885-A1 Method for the introduction of an oxygen-containing functional group into ansamycines, compounds thus obtained, and pharmaceutical compositions containing them CIBA-GEIGY AG (CH) 1981-02-11 EP disclosed